Skip to main content
Home

Main navigation

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
    • Scientific Advisory Committee
    • Awards and Recognition
    • Virtual Company Tour
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
    • Evoca™
  • Investors
    • Press releases
    • Financial information
    • Stock Information
    • Shareholder information
    • Corporate governance
    • Events
    • Presentations
    • Fact sheets
    • IPO
  • Partnering
  • News & Events
    • Press releases
    • Events
    • Stay in touch
    • Message from our CEO
  • Careers
    • Open Positions
    • Vision & Values
    • What our employees say
    • Benefits and wellbeing
  • Contact

User account menu

  • Log in

Press releases

Go back to Investors overview
June 16, 2025

Publication of transparency notification

PDF icon
EN
PDF icon
NL
June 11, 2025

Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU

PDF icon
EN
PDF icon
NL
May 26, 2025

Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer

PDF icon
EN
PDF icon
NL
May 20, 2025

Biotalys and AgroFresh Partner to Protect Fresh Produce

PDF icon
EN
PDF icon
NL
April 22, 2025

Results of the Ordinary Shareholders’ Meeting

PDF icon
EN
PDF icon
NL
March 25, 2025

Biotalys to Appoint Toni Bucci to its Board of Directors

PDF icon
EN
PDF icon
NL
March 21, 2025

Invitation to the ordinary general shareholders meeting

PDF icon
EN
PDF icon
NL
March 19, 2025

Biotalys Reports Full-Year 2024 Financial Results and Business Highlights

PDF icon
EN
PDF icon
NL
March 11, 2025

Biotalys Achieves Strong Results in Field Trials with Second Biofungicide

PDF icon
EN
PDF icon
NL
January 27, 2025

Information on the total number of voting rights and shares

PDF icon
EN
PDF icon
NL
January 14, 2025

Biotalys Provides Regulatory Review Update on EVOCA

PDF icon
EN
PDF icon
NL
October 23, 2024

Publication of transparency notifications

PDF icon
EN
PDF icon
NL
October 17, 2024

Biotalys Appoints Kamal El Mernissi as Chief Business Development Officer

PDF icon
EN
PDF icon
NL
October 16, 2024

Biotalys announces Closing of Private Placement

PDF icon
EN
PDF icon
NL
October 14, 2024

Biotalys Obtains Subscription Commitments for EUR 15 Million through a Private Placement of New Shares with New and Current Investors

PDF icon
EN
PDF icon
NL

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page >

Social Menu

  • Twitter
  • LinkedIn
  • Email

Footer navigation (primary)

  • Our Company
    • Who we are
    • Senior Leadership Team
    • Board of Directors
    • Scientific Advisory Committee
  • Our Solutions
    • AGROBODY Foundry™
    • Product pipeline
  • Investors

Footer navigation (secondary)

  • Partnering
  • Media
    • Press releases
    • Events
    • Download section
    • Stay in touch
  • Contact

Home

Biotalys NV
Buchtenstraat 11
Ghent 9051, Belgium
Phone: +32 (0)9 274 5400

info@biotalys.com

© Copyright 2025 Biotalys NV | Privacy Policy | General Purchasing Conditions